Characterization of a new model of parkinson's diisease induced by expression of alpha-synuclein in the midbrain.

Projektinformationen

ID Finanzhilfevereinbarung: QLK6-CT-2001-51860

Projekt abgeschlossen

Startdatum 1 August 2002

Enddatum 31 Juli 2004

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 150 804,00

EU-Beitrag € 150 804,00

Koordiniert durch

LUND UNIVERSITY
Sweden

Ziel

Temporal biochemical, molecular and behavioural characterization of the new Parkinson model. Study of the potential of GDNF retrovirus as a therapeutic strategy. Analysis of the susceptibility to 6-OH-dopamine of the dopaminergic system in the model.

Wissenschaftliches Gebiet

• medical and health sciences › basic medicine › neurology › parkinson

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-6. - Key action The Ageing Population and Disabilities

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

LUND UNIVERSITY

• EU-Beitrag: Keine Daten
• Adresse: Paradisgatan 2 ; 221 00 LUND ; Schweden
• Gesamtkosten: Keine Daten